Logo image of SVS.MI

SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

BIT:SVS - Euronext Milan - IT0005469264 - Common Stock - Currency: EUR

8  +0.06 (+0.76%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SVS. SVS was compared to 57 industry peers in the Health Care Equipment & Supplies industry. SVS has only an average score on both its financial health and profitability. An interesting combination arises when we look at growth and value: SVS is growing strongly while it also seems undervalued.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SVS had positive earnings in the past year.
In the past year SVS had a positive cash flow from operations.
SVS had positive earnings in each of the past 5 years.
In the past 5 years SVS always reported a positive cash flow from operatings.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

The Return On Assets of SVS (3.44%) is comparable to the rest of the industry.
SVS's Return On Equity of 9.25% is fine compared to the rest of the industry. SVS outperforms 70.18% of its industry peers.
The Return On Invested Capital of SVS (7.57%) is better than 73.68% of its industry peers.
SVS had an Average Return On Invested Capital over the past 3 years of 6.10%. This is below the industry average of 8.12%.
The last Return On Invested Capital (7.57%) for SVS is above the 3 year average (6.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROIC 7.57%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

SVS has a Profit Margin (4.49%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SVS has grown nicely.
With a Operating Margin value of 8.07%, SVS perfoms like the industry average, outperforming 49.12% of the companies in the same industry.
In the last couple of years the Operating Margin of SVS has grown nicely.
SVS's Gross Margin of 25.79% is on the low side compared to the rest of the industry. SVS is outperformed by 84.21% of its industry peers.
SVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SVS is still creating some value.
Compared to 1 year ago, SVS has less shares outstanding
SVS has less shares outstanding than it did 5 years ago.
SVS has a worse debt/assets ratio than last year.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 1.86 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SVS has a Altman-Z score (1.86) which is comparable to the rest of the industry.
SVS has a debt to FCF ratio of 1707.47. This is a negative value and a sign of low solvency as SVS would need 1707.47 years to pay back of all of its debts.
With a Debt to FCF ratio value of 1707.47, SVS perfoms like the industry average, outperforming 43.86% of the companies in the same industry.
SVS has a Debt/Equity ratio of 0.64. This is a neutral value indicating SVS is somewhat dependend on debt financing.
SVS has a Debt to Equity ratio of 0.64. This is in the lower half of the industry: SVS underperforms 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Altman-Z 1.86
ROIC/WACC1.1
WACC6.9%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.96 indicates that SVS should not have too much problems paying its short term obligations.
SVS has a Current ratio (1.96) which is comparable to the rest of the industry.
SVS has a Quick Ratio of 1.42. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
SVS has a better Quick ratio (1.42) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.42
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.52%, which is quite impressive.
SVS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.81% yearly.
SVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.19%.
SVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.34% yearly.
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%

3.2 Future

The Earnings Per Share is expected to grow by 16.90% on average over the next years. This is quite good.
Based on estimates for the next years, SVS will show a quite strong growth in Revenue. The Revenue will grow by 8.45% on average per year.
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.5 1

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.84 indicates a rather cheap valuation of SVS.
Compared to the rest of the industry, the Price/Earnings ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 98.25% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SVS to the average of the S&P500 Index (27.50), we can say SVS is valued rather cheaply.
The Price/Forward Earnings ratio is 6.09, which indicates a rather cheap valuation of SVS.
Based on the Price/Forward Earnings ratio, SVS is valued cheaply inside the industry as 96.49% of the companies are valued more expensively.
SVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 7.84
Fwd PE 6.09
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 91.23% of the companies listed in the same industry.
SVS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 1204.3
EV/EBITDA 3.56
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

SVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SVS may justify a higher PE ratio.
A more expensive valuation may be justified as SVS's earnings are expected to grow with 16.90% in the coming years.
PEG (NY)0.38
PEG (5Y)0.34
EPS Next 2Y22.24%
EPS Next 3Y16.9%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.16%, SVS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.27, SVS pays a better dividend. On top of this SVS pays more dividend than 89.47% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, SVS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y22.24%
EPS Next 3Y16.9%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

More info and screens

SVAS BIOSANA SPA

BIT:SVS (7/11/2025, 7:00:00 PM)

8

+0.06 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.77%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap44.80M
Analysts80
Price Target13.87 (73.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.68%
PT rev (3m)9.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 7.84
Fwd PE 6.09
P/S 0.37
P/FCF 1204.3
P/OCF 7.32
P/B 0.76
P/tB 0.95
EV/EBITDA 3.56
EPS(TTM)1.02
EY12.75%
EPS(NY)1.31
Fwd EY16.41%
FCF(TTM)0.01
FCFY0.08%
OCF(TTM)1.09
OCFY13.67%
SpS21.7
BVpS10.52
TBVpS8.44
PEG (NY)0.38
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROCE 9.95%
ROIC 7.57%
ROICexc 11.41%
ROICexgc 13.88%
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
FCFM 0.03%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
ROICexc(3y)9.61%
ROICexc(5y)8.9%
ROICexgc(3y)11.85%
ROICexgc(5y)10.85%
ROCE(3y)8.02%
ROCE(5y)10.69%
ROICexcg growth 3Y15.29%
ROICexcg growth 5Y7.17%
ROICexc growth 3Y14.84%
ROICexc growth 5Y6.65%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Debt/EBITDA 2.51
Cap/Depr 118.33%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 40.95%
Profit Quality 0.68%
Current Ratio 1.96
Quick Ratio 1.42
Altman-Z 1.86
F-Score8
WACC6.9%
ROIC/WACC1.1
Cap/Depr(3y)116.12%
Cap/Depr(5y)115.75%
Cap/Sales(3y)5.74%
Cap/Sales(5y)5.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3Y21.21%
EBIT growth 5Y14.92%
EBIT Next Year83.74%
EBIT Next 3Y31.21%
EBIT Next 5Y24.44%
FCF growth 1Y100.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y212.56%
OCF growth 3Y9.06%
OCF growth 5Y6.2%